Regenicin, Inc.
RGIN
$0.00
$0.000.00%
OTC PK
| 03/31/2023 | 12/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -12.89% | 82.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.50% | 82.79% | |||
| Operating Income | -22.50% | -82.79% | |||
| Income Before Tax | -21.23% | -78.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -21.23% | -78.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.23% | -78.57% | |||
| EBIT | -22.50% | -82.79% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -21.05% | -90.00% | |||
| Normalized Basic EPS | -27.27% | -83.33% | |||
| EPS Diluted | -21.05% | -90.00% | |||
| Normalized Diluted EPS | -27.27% | -83.33% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||